Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
PCE Inflation Data, ExxonMobil, Earnings: What to Watch
Express News | Gilead Expects Company's Hiv Sales to Be Roughly Flat in 2025 - Conf. Call
Express News | Gilead Exec Says It Is Unlikely That Company Will Be Engaging in Any Sizable M&a Transactions in the Near Term - Conf. Call
Gilead Sciences Q1 Tops Estimates, Updates Outlook
Gilead Sciences (GILD) late Thursday reported Q1 non-GAAP net loss of $1.32 per diluted share, compared with earnings of $1.37 last year. Analysts surveyed by Capital IQ expected a loss of $1.52 a sha
Express News | Gilead: Market Volumes in February Were Temporarily Disrupted by Cyber Attack on Change Healthcare, Volumes Readily Recovered in March - Conf. Call